These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9774303)

  • 1. Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is established.
    Bergman U; Isacsson G
    BMJ; 1998 Oct; 317(7165):1076. PubMed ID: 9774303
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of calcium channel blockers and risk of suicide. Drug perscriptions over longer period should have been followed up.
    Wiholm BE; Sundström A; Alfredsson L
    BMJ; 1998 Oct; 317(7165):1076-7. PubMed ID: 9841039
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of calcium channel blockers and risk of suicide. Perscriptions for particular drug are influenced by numerous factors.
    Chen YT; Makuch RW
    BMJ; 1998 Oct; 317(7165):1077. PubMed ID: 9841040
    [No Abstract]   [Full Text] [Related]  

  • 4. Suicide link with blood pressure drug unproven.
    Health News; 1998 Apr; 4(5):7. PubMed ID: 9563303
    [No Abstract]   [Full Text] [Related]  

  • 5. Nested case-control studies.
    Sedgwick P
    BMJ; 2010 May; 340():c2582. PubMed ID: 20484347
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide.
    Stanton AV
    BMJ; 1998 May; 316(7143):1471-3. PubMed ID: 9582126
    [No Abstract]   [Full Text] [Related]  

  • 8. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study.
    Olesen JB; Gislason GH; Charlot MG; Fosbøl EL; Andersson C; Weeke P; Ahlehoff O; Selmer C; Torp-Pedersen C; Hansen PR
    J Am Coll Cardiol; 2011 Jan; 57(4):409-17. PubMed ID: 21251580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.
    Packer M
    Circulation; 1989 Dec; 80(6 Suppl):IV59-67. PubMed ID: 2688986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gingival hyperplasia induced by calcium channel blockers. Rare or frequent in Norway?].
    Løkken P; Skomedal T
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1978-80. PubMed ID: 1509464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tocolysis with calcium-channel blockers and intraventricular hemorrhage].
    Nguon B; Zupan-Simunek V; Audibert F; Preaux N
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):287-92. PubMed ID: 17395401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study.
    Cox NH; Walsh ML; Robson RH
    Clin Exp Dermatol; 2009 Jun; 34(4):487-91. PubMed ID: 19094124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical implications in patients after calcium channel blockers overdose--own observations].
    Stachoń K; Dabek J; Jakubowski D; Rychlik W
    Pol Merkur Lekarski; 2011 Sep; 31(183):145-9. PubMed ID: 21991842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of calcium antagonists: more ACTION.
    Messerli FH; Staessen JA
    Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of calcium channel blockers in general practice.
    Tonkin A; Frewin D
    Aust Fam Physician; 1993 Mar; 22(3):389-95. PubMed ID: 8466450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
    Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
    Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.